THE PRESENT APPLICATION RELATES TO A PHARMACEUTICAL COMPOSITION COMPRISING FESOTERODINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF AND A STABILIZER SELECTED FROM THE GROUP CONSISTING OF XYLITOL, SORBITOL , POLYDEXTROSE, ISOMALT AND DEXTROSE.